Moleculin Biotech Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 47.25 K | $131.83 K | 46.16% | 0.83% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 42.22 K | $117.78 K | 204.38% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 29.88 K | $83.37 K | 392.14% | 0.53% |
| XTX TOPCO LTD | 08/14/2026 | 22.94 K | $64.01 K | 100.00% | 0.40% |
| MORGAN STANLEY | 08/13/2026 | 20.04 K | $55.90 K | 55,555.56% | 0.35% |
| ROCKEFELLER CAPITAL MANAGEMENT L.P. | 08/13/2026 | 15.00 K | $41.85 K | 239.29% | 0.26% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 3.51 K | $9.80 K | 91.50% | 0.06% |
| CITIGROUP INC | 08/03/2026 | 2.67 K | $7.46 K | 100.00% | 0.05% |
| BARCLAYS PLC | 08/14/2026 | 621 | $1.73 K | 100.00% | 0.01% |
| BLACKROCK, INC. | 08/07/2026 | 491 | $1.37 K | 0.00% | 0.01% |
| EFG INTERNATIONAL AG | 08/14/2026 | 434 | $1.21 K | 0.00% | 0.01% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 360 | $1.18 K | 100.00% | 0.01% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 200 | $558 | 100.00% | 0.00% |
| NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 08/14/2026 | 114 | $318 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 44 | $123 | 2.33% | 0.00% |
| DANSKE BANK A/S | 08/10/2026 | 2 | $6 | 0.00% | 0.00% |
| CVA FAMILY OFFICE, LLC | 08/07/2026 | 1 | $3 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 1 | $2 | 0.00% | 0.00% |
| FMR LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| HRT FINANCIAL LP | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SABBY MANAGEMENT, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 0 | $0 | -100.00% | 0.00% |
Moleculin Biotech Inc institutional Ownership - FAQ's
During the previous two years, 29 institutional investors and hedge funds held shares of Moleculin Biotech Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 47,252
VANGUARD CAPITAL MANAGEMENT LLC: 42,215
VANGUARD FIDUCIARY TRUST CO: 29,883
XTX Topco Ltd: 22,942
MORGAN STANLEY: 20,036
Rockefeller Capital Management L.P.: 15,000
3.27% of Moleculin Biotech Inc stock is owned by institutional investors.
Institutional investors have bought a total of 214.23 K shares in the last 24 months. This purchase volume represents approximately $419.88 K in transactions.